E&L from Single-Use Systems and Their Assessment in Advanced Therapy Medicinal Product production
29:33
Good Identification Practices in Non-Targeted Screening Analyses
33:14
Considerations for Validation of Filters used in (Bio)Pharmaceutical Manufacturing
25:58
Movement Terminology
25:38
Qualification of Single Use Materials for Biopharmaceutical Manufacturing
55:29
Implementation of an Improved Platform for Downstream Processing of Plasmid DNA
27:24
Assuring Viral Safety of the Biopharmaceutical Process
32:07
Cytiva Approach for E&L Qualification and Risk Assessment of a Single-Use System: Case Studies
57:41